RVTY
Revvity, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth -7.7% ·
share flow 0.0% ·
net new positions -8.3%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 133 | +9 | 66.02M | $7.35B | +14 | −4 |
| Q1 2026 | 126 | -7 | 72.99M | $6.39B | +4 | −12 |
| Q4 2025 | 133 | 0 | 75.39M | $7.30B | +3 | −2 |
| Q3 2025 | 19 | +1 | 44.69M | $3.92B | +1 | −1 |
| Q2 2025 | 16 | +1 | 42.02M | $4.06B | +3 | −2 |
| Q1 2025 | 12 | -1 | 20.50M | $2.17B | — | −1 |
| Q4 2024 | 13 | 0 | 18.11M | $2.02B | +1 | −1 |
| Q3 2024 | 12 | -1 | 11.86M | $1.51B | +1 | −2 |
| Q2 2024 | 13 | — | 11.86M | $1.24B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 6.48M | +21.7% | $827.79M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 6.48M | +21.7% | $827.79M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 2.86M | +0.9% | $364.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 2.86M | +0.9% | $364.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 1.20M | +5.3% | $153.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 933.30K | -3.5% | $119.23M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 137.06K | -79.3% | $17.51M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Gotham Asset Management ✦ | 118.71K | +51.2% | $15.17M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 66.29K | -69.7% | $8.47M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Fisher Asset Management ✦ | 40.62K | +3.9% | $5.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 6.31K | +12.1% | $798,171 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 6.31K | +12.1% | $798,171 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 6.31K | +12.1% | $798,171 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 5.88K | -10.4% | $751,043 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 5.88K | -10.4% | $751,043 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 3.50K | -96.1% | $446,870 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 3.40K | New | $434,350 | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 3.40K | New | $434,350 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $434,350 | 0.0% |
| Marshall Wace | $434,350 | 0.0% |
Exited
| Citadel Advisors | $51.34M | was 0.1% |
| Bridgewater Associates | $221,569 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 495 holders, 115.11M shares, $7.19B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.